Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 9 open reading frame 163 (C9orf163) is an uncharacterized human protein encoded by the C9orf163 gene. It is sometimes referred to by its clone name FLJ36779. To date, no specific biological function, molecular pathway, or disease association has been validated for this gene. It is a protein of unknown function and currently not classified within any major molecular family such as receptors, enzymes, or channels, and there are no approved or experimental drugs known to act on this protein. Its protein sequence is cataloged in human gene databases, but there is no experimental evidence for its relevance as a drug target or biomarker.
None (No therapeutically relevant mechanisms of action established for this molecule.)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 9 open reading frame 163 (C9orf163).